Dynavax Technologies Corp (DVAX) concluded trading on Thursday at a closing price of $14.34, with 17.36 million shares of worth about $249.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.80% during that period and on March 06, 2025 the price saw a gain of about 2.36%. Currently the company’s common shares owned by public are about 125.45M shares, out of which, 118.57M shares are available for trading.
Stock saw a price change of 5.60% in past 5 days and over the past one month there was a price change of 10.31%. Year-to-date (YTD), DVAX shares are showing a performance of 12.29% which increased to 12.56% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $9.74 but also hit the highest price of $14.11 during that period. The average intraday trading volume for Dynavax Technologies Corp shares is 1.72 million. The stock is currently trading 7.64% above its 20-day simple moving average (SMA20), while that difference is up 10.36% for SMA50 and it goes to 20.64% higher than SMA200.
Dynavax Technologies Corp (NASDAQ: DVAX) currently have 125.45M outstanding shares and institutions hold larger chunk of about 101.93% of that.
The stock has a current market capitalization of $1.78B and its 3Y-monthly beta is at 1.25. PE ratio of stock for trailing 12 months is 82.08, while it has posted earnings per share of $0.17 in the same period. Its PEG reads 1.49 and has Quick Ratio of 9.91 while making debt-to-equity ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DVAX, volatility over the week remained 3.20% while standing at 3.19% over the month.
Analysts are in expectations that Dynavax Technologies Corp (DVAX) stock would likely to be making an EPS of 0.05 in the current quarter, while forecast for next quarter EPS is 0.09 and it is 0.54 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.03 which is 0.06 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.07 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 75.00% while it is estimated to increase by 64.57% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on February 11, 2025 offering a Sell rating for the stock and assigned a target price range of between $15 and $12 to it. Coverage by Goldman stated Dynavax Technologies Corp (DVAX) stock as a Neutral in their note to investors on February 01, 2024, suggesting a price target of $20 for the stock. On September 27, 2022, JMP Securities Initiated their recommendations, while on January 06, 2022, Goldman Resumed their ratings for the stock with a price target of $38. Stock get a Buy rating from Goldman on August 06, 2021.
